⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for adenocarcinomas

Every month we try and update this database with for adenocarcinomas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung CancerNCT03215810
Non-Small Cell ...
Metastatic Non-...
Squamous Cell C...
Advanced NSCLC
Adenosquamous C...
Adenocarcinomas
Tumor-infiltrat...
Nivolumab
Cyclophosphamid...
Fludarabine
Tumor-infiltrat...
Interleukin-2 (...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)NCT04699071
Adenocarcinomas
Recurrent Gynec...
pembrolizumab a...
21 Years - 99 YearsNational University Hospital, Singapore
Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)NCT04699071
Adenocarcinomas
Recurrent Gynec...
pembrolizumab a...
21 Years - 99 YearsNational University Hospital, Singapore
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: